PTC Announces CFO Transition

Jennifer DiRico Appointed as Next Chief Financial Officer

PTC (NASDAQ: PTC) today announced that Jennifer DiRico has been appointed Executive Vice President and Chief Financial Officer, effective January 1, 2026. DiRico will report to President and Chief Executive Officer Neil Barua and lead the Company's global finance organization. DiRico succeeds Kristian Talvitie, who will continue to serve as CFO through December 31, 2025. DiRico's appointment is the culmination of a thorough executive search process.

DiRico is an accomplished finance and business operations leader with experience ranging from large-scale enterprise software organizations to high-growth technology companies. She currently serves as Chief Financial Officer of Commvault, a leading cyber resilience company. Prior to Commvault, DiRico spent several years at Toast in finance and operations leadership roles. She played a key role in Toast's successful IPO and served as General Manager of the Company's international business while leading its global expansion strategy.

"Jen has a proven track record of leading high-performing teams through periods of transformation and growth," said Barua. "This track record, together with her leadership at the intersection of finance and operations, will be invaluable to PTC as we advance our Intelligent Product Lifecycle vision. I look forward to partnering with Jen as we build on our momentum to address our customers' most pressing challenges and drive compelling, sustainable value for PTC's shareholders."

"PTC has a leading portfolio of product lifecycle software solutions and plays a critical role in its customers' digital transformations, from the world's largest, most complex organizations to the fast-growing startups redefining industries," said DiRico. "I'm excited to partner with Neil and the global team and help PTC capture its growth opportunity while maintaining strong financial discipline to deliver meaningful results."

Barua continued, "I want to express our sincerest gratitude to Kristian for his contributions to PTC, most notably his role in our transition to a subscription business model and the diligence he has brought to PTC's free cash flow performance over the last several years. We wish him the best moving forward."

Full Fiscal Year 2026 and First Fiscal Quarter Guidance

PTC affirmed its full fiscal year 2026 and first fiscal quarter guidance as previously announced on November 5, 2025.

About Jennifer DiRico

Jennifer DiRico is currently Chief Financial Officer of Commvault, a leading provider of cloud-based and on-premises cyber resilience and data security and recovery solutions for companies worldwide. Before joining Commvault in 2024, she served in senior finance and operating roles for nearly a decade at Toast, a comprehensive platform of software as a service (SaaS) products and financial technology solutions for restaurants. Prior to Toast, DiRico held finance positions at Nuance Communications and earlier at Passkey International.

Forward-Looking Statements

Statements in this press release that are not historic facts, including statements about our future operating, financial and growth expectations and guidance, are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those projected. These risks include: the macroeconomic and/or global manufacturing climates may not improve or may deteriorate, which could cause customers to delay or reduce purchases of new software, adopt competing software solutions, reduce the number of subscriptions they carry, or delay payments to us, which would adversely affect our ARR (Annual Run Rate) and/or financial results and cash flow and growth; our investments in our software solutions may not drive expansion of those solutions and/or generate the ARR and/or cash flow we expect if customers are slower to adopt those solutions than we expect or if they adopt competing solutions; customers may not build the product data foundations essential for the AI-driven transformation of their business when or as we expect, which could adversely affect our ARR and/or financial results and cash flow and growth; our go-to-market realignment and related initiatives may disrupt our business to a greater extent than we expect or may not generate the ARR and/or financial results or cash flow when or as we expect; and foreign exchange rates may differ materially from those we expect. In addition, our assumptions concerning our future GAAP and non-GAAP effective income tax rates are based on estimates and other factors that could change, including changes to tax laws in the U.S. and other countries and the geographic mix of our revenue, expenses, and profits. Other risks and uncertainties that could cause actual results to differ materially from those projected are described from time to time in reports we file with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K and other filings with the U.S. Securities and Exchange Commission.

About PTC (NASDAQ: PTC)

PTC (NASDAQ: PTC) is a global software company that enables manufacturers and product companies to digitally transform how they design, manufacture, and service the physical products that the world relies on. Headquartered in Boston, Massachusetts, PTC employs over 7,000 people and supports more than 30,000 customers globally. For more information, please visit www.ptc.com.

@PTC Blogs

Media Contact
Greg Payne
gpayne@ptc.com 

Investor Relations Contact
Matt Shimao
mshimao@ptc.com
investor@ptc.com

PTC and the PTC logo are trademarks or registered trademarks of PTC Inc. and its subsidiaries in the United States and other countries.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/ptc-announces-cfo-transition-302633586.html

SOURCE PTC Inc.

News Provided by PR Newswire via QuoteMedia

PTC
The Conversation (0)
Stock Trend Capital

Stock Trend Capital Announces Loan to eGOD Digital Labs for Dogecoin Mining

Stock Trend Capital Inc. (CSE: PUMP) (FSE: P0G) (PTC Pink: STOCF) (the "Company" or "Stock Trend") announces that the Company has entered into a loan agreement (the "Loan Agreement") dated January 7, 2025, with 1001070426 Ontario Inc. dba eGOD Digital Labs ("eGod" or "the "Borrower"), whereby... Keep Reading...
Five-year Data for Genentech's Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy  Achieved or Maintained the Ability to Sit, Stand or Walk

Five-year Data for Genentech's Evrysdi Show the Majority of Treated Children With a Severe Form of Spinal Muscular Atrophy Achieved or Maintained the Ability to Sit, Stand or Walk

- After 5 years of treatment, 91% of children were alive — without treatment, children with Type 1 SMA would not be expected to live past 2 years of age - - 96% of Evrysdi-treated children could swallow, 80% could feed without a feeding tube and 59% could sit without support for at least 30... Keep Reading...
Cisco Reveals Nexus HyperFabric AI Clusters, A New Simplified Data Center Infrastructure Solution with NVIDIA for Generative AI

Cisco Reveals Nexus HyperFabric AI Clusters, A New Simplified Data Center Infrastructure Solution with NVIDIA for Generative AI

News Summary: The new solution will combine Cisco and NVIDIA innovation to simplify the deployment of generative AI applications, providing IT visibility and analytics across the entire AI infrastructure stack. Cisco Nexus HyperFabric AI clusters make it easy for enterprise customers to build... Keep Reading...
Charbone Hydrogen Receives Independent Valuation of US $60.8 Million And Anticipates Significant Growth Economics for North American Green Hydrogen Production Facilities Rollout

Charbone Hydrogen Receives Independent Valuation of US $60.8 Million And Anticipates Significant Growth Economics for North American Green Hydrogen Production Facilities Rollout

(TheNewswire) Brossard, Quebec, MAY 14, 2024 TheNewswire - Charbone Hydrogen Corporation (TSXV: CH; OTCQB: CHHYF; FSE: K47) (the "Company" or "CHARBONE"), North America's only publicly traded pure-play green hydrogen company, today announced that the Company has received a US$60.8 Million... Keep Reading...
"investingnews.com"

Northstar Applies to Cross Trade on the OTCQB Venture Market in the US

Northstar Clean Technologies Inc. (TSXV: ROOF) ("Northstar" or the "Company") announces that it has filed its application for its common shares to be cross traded on the OTCQB Venture Market (the "OTCQB"). The OTCQB market provides a platform for a wide variety of companies to be able to trade... Keep Reading...
Quantum Biopharma

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Reward to be Paid if Information Contributes Significant Evidence Leading to a Trial Victory or Settlement in Landmark USD $700 Million+ Lawsuit

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol... Keep Reading...
Imagion Biosystems

Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging technology, is pleased to provide shareholders with a progress update regarding the Company’s business and... Keep Reading...
Stethoscope on stacked gold coins, symbolizing healthcare costs or medical finance.

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare. But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no... Keep Reading...
Actinogen

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

Actinogen Medical ASX: ACW (“ACW” or “the Company”) is pleased to announce that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer’s disease (AD) has now passed all screening tests and is scheduled for randomization and treatment in July. This... Keep Reading...
Emyria Limited

Medibank to Fund Emyria’s PTSD Program at Perth Clinic

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) a leader in developing and delivering innovative mental health treatments, is pleased to announce that Medibank Private Limited (“Medibank”), Australia’s largest private health insurer, has commenced funding for eligible customers to access... Keep Reading...
ASX:HIQ

HITIQ Announces Exclusive Global Agreement with Shock Doctor for PROTEQT Instrumented Mouthguard

Common Shareholder Questions – Entitlement Offer

HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world’s leading mouthguard innovator. This landmark agreement marks Shock Doctor’s two-year effort to design a mouthguard that will... Keep Reading...

Latest Press Releases

Related News